Drug retention rate of Janus kinase inhibitors in patients with rheumatoid arthritis: the KEIO-RA cohort study

Drug retention rate of Janus kinase inhibitors in patients with rheumatoid arthritis: the KEIO-RA cohort study

<p>This study aimed to investigate the effectiveness and safety of Janus kinase inhibitors (JAKis) in patients with rheumatoid arthritis (RA) in the real world. All consecutive patients with RA from the KEIO-RA cohort who had received a JAKi from July 2013 to June 2023 were included. We assess...

Descrición completa

Gardado en:
Detalles Bibliográficos
Autor Principal: Satoshi Takanashi (15221350) (author)
Outros autores: Masatoshi Kawai (2074750) (author), Mitsuhiro Akiyama (3412106) (author), Yasushi Kondo (371654) (author), Shuntaro Saito (4519816) (author), Masaru Takeshita (6197132) (author), Jun Kikuchi (266172) (author), Hironari Hanaoka (3910738) (author), Yuko Kaneko (839653) (author)
Publicado: 2025
Subjects:
Biochemistry
Medicine
Pharmacology
Biotechnology
Ecology
Immunology
Developmental Biology
Science Policy
Chemical Sciences not elsewhere classified
Rheumatoid arthritis
JAK inhibitors
difficult-to-treat rheumatoid arthritis
retention rates
effectiveness
safety
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares